Cybin Inc. (NEO:CYBN)
Canada
· Delayed Price · Currency is CAD 8.38
-0.75 (-8.21%)
Apr 1, 2025, 3:54 PM EST
Cybin Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
50
Market Cap
177.93M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | 864.00K | - | - |
| Mar 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 893.16M |
| WELL Health Technologies | 957.69M |
| Extendicare | 1.47B |
| Trulieve Cannabis | 1.71B |
| Cronos Group | 169.23M |
| Curaleaf Holdings | 1.93B |
Cybin News
- 19 days ago - Cybin wins new Buy from Guggenheim: potential to challenge J&J’s Spravato cited - Seeking Alpha
- 7 weeks ago - Cybin reports Q3 results - Seeking Alpha
- 7 weeks ago - Cybin Reports Third Quarter Fiscal Year 2025 Financial Results and Recent Business Highlights - Business Wire
- 2 months ago - Cybin: Paradigm Changing Ambitions - Seeking Alpha
- 2 months ago - Cybin enters partnership agreement to conduct phase 3 trial for depression candidate - Seeking Alpha
- 2 months ago - Cybin Launches Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Pivotal Phase 3 Program Evaluating CYB003 for the Adjunctive Treatment of Major Depressive Disorder - Business Wire
- 2 months ago - Cybin Highlights 2024 Accomplishments and Upcoming Milestones for 2025 - Business Wire
- 2 months ago - Cybin to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025 - Business Wire